Globus Medical Reports Second Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Globus Medical (GMED) PT Raised to $100 at Northland Capital Markets
August 5, 2021 7:36 AM EDTNorthland Capital Markets analyst Jason Wittes raised the price target on Globus Medical (NYSE: GMED) to $100.00 while maintaining an Outperform rating.
The analyst commented, "GMED reported record revenues in 2Q21 of $251.0 million, up 68.6% y/y (up 67.9% cc y/y), easily beating consensus of... More
Globus Medical (GMED) Tops Q2 EPS by 12c
August 4, 2021 4:51 PM EDTGlobus Medical (NYSE: GMED) reported Q2 EPS of $0.56, $0.12 better than the analyst estimate of $0.44. Revenue for the quarter came in at $251 million versus the consensus estimate of $224.64 million.
GUIDANCE:
Globus Medical sees FY2021 EPS of $1.89-$2.00, versus the consensus of... More
